Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Growing Demand: The Hematocrit Test market is witnessing a steady rise in demand due to increasing incidences of blood-related disorders and chronic diseases such as anemia and leukemia.
Advancements in Technology: Technological advancements in Hematocrit testing methods, such as the development of automated analyzers and point-of-care testing devices, are driving market growth by providing accurate and efficient testing solutions.
Increasing Healthcare Expenditure: The rise in healthcare expenditure, particularly in emerging economies, is contributing to the expansion of the Hematocrit Test market as healthcare facilities invest in upgrading their diagnostic capabilities.
Rising Geriatric Population: With the global population aging, there is a higher prevalence of age-related conditions that require regular blood monitoring, leading to an increased demand for Hematocrit testing.
Diagnostic Accuracy: The Hematocrit Test's ability to provide quick and accurate results is a key factor driving its adoption in various healthcare settings, including hospitals, clinics, and diagnostic laboratories.
Regulatory Landscape: Stringent regulatory guidelines governing the approval and usage of medical devices influence the Hematocrit Test market dynamics, with manufacturers needing to comply with standards to ensure product safety and efficacy.
Competitive Landscape: The Hematocrit Test market is characterized by intense competition among key players, leading to innovations in product development, strategic collaborations, and mergers and acquisitions to gain a competitive edge.
Patient Awareness and Education: Increasing awareness among patients regarding the importance of regular blood testing for early detection and management of health conditions is driving the demand for Hematocrit tests.
Cost-Effectiveness: The affordability and cost-effectiveness of Hematocrit testing compared to other diagnostic methods make it a preferred choice, especially in resource-limited settings.
Global Health Initiatives: Initiatives by international organizations and governments to improve healthcare infrastructure and promote preventive healthcare measures are expected to fuel the growth of the Hematocrit Test market globally.
Market Fragmentation: The Hematocrit Test market is fragmented, with numerous regional and global players offering a wide range of products and services, leading to price competition and market saturation in some regions.
Emerging Markets: Emerging markets, particularly in Asia-Pacific and Latin America, present significant growth opportunities for Hematocrit Test market players due to the growing healthcare infrastructure and increasing adoption of diagnostic technologies.
COVID-19 Impact: The COVID-19 pandemic has highlighted the importance of diagnostic testing, including Hematocrit tests, in managing public health crises, leading to increased investments in diagnostic capabilities and research in the field.
Patient-Centric Approach: Healthcare providers are increasingly adopting a patient-centric approach, focusing on personalized medicine and preventive care, which is expected to drive the demand for Hematocrit testing in the coming years.
Covered Aspects:
| Report Attribute/Metric | Details |
|---|
Hematocrit Test Market Highlights:
Hematocrit Test Market Overview
The hematocrit test market is anticipated to reach USD 3201.44 Million by 2030 at 5.9% CAGR during the forecast period 2022-2030.Also known as packed-cell volume (PCV) test, hematocrit test is used to measure the percentage of Red Blood Cells (RBCs) in the blood. The major function of the RBCs is to carry blood throughout the body. The test is usually performed to diagnose various diseases such as anemia, leukemia, lymphoma, congenital heart disease, and others. The test determines the elevation in the percentage of normal RBCs which is 38.8%-50% in men and 34.9%-44.5% in women. The hematocrit test is one of the tests included under complete blood count (CBC) test.
Cardiovascular diseases, cancer, and kidney diseases are increasing the economic burden of various developing and developed nations across the globe. The hematocrit test market is driven by rising prevalence of chronic diseases such as cardiovascular diseases, diabetes, and others along with changing lifestyle, and increasing demand for diagnostic devices for cardiovascular diseases. However, limited number of trained personnel has restrained the growth of the hematocrit test market. However, the high cost of diagnosis and treatment of cardiovascular diseases also restrains the growth of the market. As per the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the overall prevalence of Chronic Kidney Disease (CKD) in the general population across the globe is nearly 14%. However, the growth of the hematocrit test market is restrained by the inaccurate or misleading result of the test and unawareness about hematocrit test in the diagnosis of the disease.
FIGURE 1: Global Hematocrit Test Market by Type, 2016 (%)
 
Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation
Segments Â
The hematocrit test market is segmented on the basis of product, indication, devices, and end-user.
On the basis of product, the hematocrit test market is segmented into the analyzer, hematocrit test meter, and others.
On the basis of indication, the hematocrit test market is segmented into anemia, leukemia, lymphoma, congenital heart disease, kidney tumor, and others.
On the basis of the end-user, the hematocrit test market is segmented into hospitals & clinics, diagnostic centers, and others.
Intended Audience
- Medical Device Manufacturers
- Medical Device Suppliers
- Medical Research Laboratories
- Research and Development (R&D) Companies
- Market Research and Consulting Service Providers
- Potential Investors
Research Methodology
 
Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation
Regional Analysis of the Hematocrit Test Market        The hematocrit test market consists of four major regions namely, the Americas, Europe, Asia Pacific and the Middle East & Africa, with the Americas capturing the largest market share. The growth of the market is attributed to an increase in the demand for diagnostic procedures, and rising importance of hematology testing for the diagnosis of various chronic diseases. North America accounts for the major share in the American hematocrit test market which is attributed to extensive use of hematocrit test with other diagnostic tests. According to the Center for the Disease Control and Prevention (CDC), as of 2012, nearly half of all the adults, 117 million population in the U.S. had one or more chronic health conditions. One in four adults were diagnosed with two or more chronic health diseases.In Europe, the growth of the market is driven by increasing demand for diagnostic devices and instrument in hospitals and diagnostic centers. Germany, the U.K, and France are the major contributors to the growth of the market owing to an increase in the number of key players engaged in the manufacturing of medical devices and instruments and rising expenditure in research and development by these major economies. Additionally, well-developed healthcare sector, ever-increasing patient population and high healthcare expenditure by the European nations fuel the market growth.The Asia Pacific is expecting the fastest growth in the market due to the flourishing growth of healthcare industries in developing economies such as India. Additionally, the ever-increasing prevalence of kidney diseases and cardiovascular diseases and rising demand for quality devices in the healthcare sector is expected to lead the use of advanced equipment, which, in turn, may speed up the market growth in the region. Rising geriatric population with chronic diseases further creates the economic burden on the developing nations thereby accelerating the market growth.The Middle East & Africa hold the least share in the market. The market in this regions exhibits steady growth owing to an increase in the demand for the diagnostic and treatment services.  In the Middle East and Africa, the United Arab Emirates (UAE) hold the largest market share owing to the availability of diagnostic and treatment services. Africa shows slow growth due to low technology penetration in developing countries.Key Players in the Hematocrit Test Market Some of the key players in hematocrit test market are Abbott (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Siemens AG (Germany), Beckman Coulter, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Horiba, Ltd. (Japan), Mindray Medical International Limited (China), Boule Diagnostics AB (Sweden), Nihon Kohden Corporation (Japan), Sysmex Corporation (Japan), and others.
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
